Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine

Journal of Evidence-based Medicine
Xue-Ting LiuDeying Kang

Abstract

To examine the reporting characteristics and key methodological factors of randomized controlled trials (RCTs) in the field of traditional Chinese medicine and assess whether use of the Consolidated Standards of Reporting Trials (CONSORT) statement is associated with improvement in the quality of reports of RCTs. RCTs published in two major traditional Chinese medicine journals were retrieved and were systematically reviewed. Of those journals, one adopted the CONSORT statement (Journal of Chinese Integrative Medicine (JCIM)) and one did not (Chinese Journal of Integrative Medicine (CJIM)). Items within the CONSORT 2001 and the CONSORT 2010 statements were taken to develop a 63-item coding manual. The Jadad scale was also used to assess methodological quality of RCTs. Two observers assessed the reporting of reports and extracted data independently. P < 0.05 was considered statistically significant. SPSS was used for all analyses. A total of 76 RCTs were included for the analysis (38 from JCIM and 38 from CJIM). Significant improvements both in the overall quality of reporting (CONSORT score) and reporting of methodological items (Jadad scale) over time were observed in adopter journal (JCIM) (P = 0.001). Overall CONSORT score o...Continue Reading

References

Jun 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A LiberatiT C Chalmers
Jun 3, 1982·The New England Journal of Medicine·R DerSimonianF Mosteller
Nov 4, 1982·The New England Journal of Medicine
Feb 1, 1995·JAMA : the Journal of the American Medical Association·K F SchulzD G Altman
Jan 1, 1995·Journal of Clinical Epidemiology·R PetoR Gray
Apr 5, 1995·JAMA : the Journal of the American Medical Association·D Rennie
Jul 13, 1994·JAMA : the Journal of the American Medical Association·D MoherG A Wells
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Aug 28, 1996·JAMA : the Journal of the American Medical Association·C BeggD F Stroup
Aug 28, 1996·JAMA : the Journal of the American Medical Association·D Rennie
Aug 31, 1996·Lancet·D McNamee, R Horton
Sep 7, 1996·BMJ : British Medical Journal·D G Altman
Jul 24, 1998·JAMA : the Journal of the American Medical Association·M Clarke, I Chalmers
Mar 21, 2000·Archives of Dermatology·K Adetugbo, H Williams
Apr 17, 2001·Annals of Internal Medicine·D G AltmanUNKNOWN CONSORT GROUP (Consolidated Standards of Reporting Trials)
Apr 20, 2001·JAMA : the Journal of the American Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards for Reporting of Trials)
Apr 20, 2001·JAMA : the Journal of the American Medical Association·M EggerUNKNOWN CONSORT Group (Consolidated Standards of Reporting of Trials)
Jul 7, 2001·BMJ : British Medical Journal·P JüniM Egger
Mar 12, 2002·The Journal of Bone and Joint Surgery. American Volume·Mohit BhandariPaul Tornetta
Jun 1, 2002·JAMA : the Journal of the American Medical Association·Mike ClarkeIain Chalmers
Jun 1, 2002·JAMA : the Journal of the American Medical Association·Karin Huwiler-MüntenerMatthias Egger
Jun 1, 2002·JAMA : the Journal of the American Medical Association·Jim NuovoDenise Chang
Aug 20, 2002·Complementary Therapies in Medicine·H MacPhersonR Niemtzow
Jan 18, 2003·Vaccine·Vance W Berger, Jeffrey D Bears
Apr 5, 2003·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Alejandro Elorriaga ClaracoAngelica Fargas-Babjak
Jun 23, 2004·British Journal of Clinical Pharmacology·Edward MillsGordon Guyatt
Mar 30, 2005·Lancet·An-Wen Chan, Douglas G Altman
Aug 2, 2005·Contemporary Clinical Trials·Edward J MillsP J Devereaux
Mar 8, 2006·Annals of Internal Medicine·Joel J GagnierUNKNOWN CONSORT Group
Jun 3, 2006·Pediatrics·Heidi AnttilaMarjukka Mäkelä
Jun 24, 2006·Explore : the Journal of Science and Healing·David MoherUNKNOWN CONSORT Group
Sep 2, 2006·The American Journal of Medicine·Joel J GagnierClaire Bombardier
Sep 5, 2006·The Medical Journal of Australia·Amy C PlintIsabelle Gaboury
Feb 13, 2007·Journal of Clinical Epidemiology·Robert L KaneJudith Garrard
Nov 22, 2007·International Journal of Surgery·Riaz AghaGordon Muir
Jun 28, 2008·The Journal of Clinical Endocrinology and Metabolism·Lorena P RiosLehana Thabane

❮ Previous
Next ❯

Citations

Sep 29, 2015·BMC Medicine·Ana Marušić
Jul 9, 2016·BMC Musculoskeletal Disorders·Andrew FinneyKrysia S Dziedzic
Jan 18, 2017·Journal of Paediatrics and Child Health·Ping HeXiaoying Zheng
Oct 27, 2017·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Menghua ChenBrian H May

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.